New Drug Application for Remdesivir Submitted
Remdesivir is an investigational nucleotide analogue with broad-spectrum antiviral activity.
Diagnosis & Disease Information
Legionnaires’ Disease-Associated Hospitalizations Spiked Between 2006 and 2010
Research results underscore the importance of understanding the characteristics of Legionnaires’ disease and the need for early diagnosis.
Pediatric Fecal Viral Shedding Examined as Route of COVID-19 Transmission
Although children appear to be at low risk for COVID-19, data suggests that prolonged fecal viral shedding may position children as potential carriers of the virus.
Antibiotic Prescribing High in Low-, Middle-Income Countries
Antibiotic prescription rates are high in low- and middle-income countries, with a pooled prevalence proportion of antibiotic prescribing of 52%.
CVD, Non-CVD Mortality Increased With Azithromycin Use
Outpatient azithromycin use is associated with an increased risk for cardiovascular and noncardiovascular mortality.
HPV Vaccine Toolkit Increases Vaccination Rates in Primary Care
The purpose of this project is to implement and evaluate the effectiveness of the 4 Pillars Practice Transformation Program to increase uptake of the HPV vaccine among pediatric patients.
Delayed Vaccination Enabled Measles Spread During 2018-2019 in NYC
Delayed vaccination enabled the initial spread and increased infectious contact facilitated transmission of measles in the 2018 to 2019 outbreak in New York City.
Cleaning Bundle Cost-Effective for Preventing Hospital-Associated Infection
Implementation of an environmental cleaning bundle in Australia was associated with a decrease in infectious caused by S aureus and vancomycin-resistant enterococci.
IDSA Issues Updated Statement on Use of Telemedicine and Telehealth Technologies
The Infectious Disease Society of America issued an updated statement supporting the appropriate use of telemedicine and telehealth technologies in clinical care, research, and education.
Buyers’ Clubs to Improve HCV Treatment Access
As part of the World Health Organization’s goal to eliminate viral hepatitis as a global health threat by 2030, the incidence of chronic new infections must decrease by 90%.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...